Spasticity

Handbook of Clinical Neurology

Volumn 109, Issue , 2012, Pages 197-211

  Dietz, Volker ^a   Sinkjaer, Thomas ^b  

^a BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867798404     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52137-8.00012-7     Document Type: Chapter

References (162)

1. Abbruzzese G. The medical management of spasticity. Eur J Neurol 2002, 9:30-34. discussion 53-61.
2. Al-Khodairy A.T., Gobelet C., Rossier A.B. Has botulinum toxin type A a place in the treatment of spasticity in spinal cord injury patients?. Spinal Cord 1998, 36:854-858.
3. Andersen O.K., Finnerup N.B., Spaich E.G., et al. Expansion of nociceptive withdrawal reflex receptive fields in spinal cord injured humans. Clin Neurophysiol 2004, 115:2798-2810.
4. Barbeau H., Fung J. New experimental approaches in the treatment of spastic gait disorders. Movement Disorders in Children 1992, Vol. 36:234-246. Karger, Basel.
5. Barnes M.P., Kent R.M., Semlyen J.K., et al. Spasticity in multiple sclerosis. Neurorehabil Neural Repair 2003, 17:66-70.
6. Bass B., Weinshenker B., Rice G.P., et al. Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis. Can J Neurol Sci 1988, 15:15-19.
7. Bennett D.J., Sanelli L., Cooke C.L., et al. Spastic long-lasting reflexes in the awake rat after sacral spinal cord injury. J Neurophysiol 2004, 91:2247-2258.
8. Beres-Jones J.A., Johnson T.D., Harkema S.J. Clonus after human spinal cord injury cannot be attributed solely to recurrent muscle-tendon stretch. Exp Brain Res 2003, 149:222-236.
9. Berger W., Horstmann G., Dietz V. Tension development and muscle activation in the leg during gait in spastic hemiparesis: independence of muscle hypertonia and exaggerated stretch reflexes. J Neurol Neurosurg Psychiatry 1984, 47:1029-1033.
10. Bes A., Eyssette M., Pierrot-Deseilligny E., et al. A multi-centre, double-blind trial of tizanidine, a new antispastic agent, in spasticity associated with hemiplegia. Curr Med Res Opin 1988, 10:709-718.
11. Boorman G., Hulliger M., Lee R.G., et al. Reciprocal Ia inhibition in patients with spinal spasticity. Neurosci Lett 1991, 127:57-60.
12. Boviatsis E.J., Kouyialis A.T., Korfias S., et al. Functional outcome of intrathecal baclofen administration for severe spasticity. Clin Neurol Neurosurg 2005, 107:289-295.
13. Burke D., Ashby P. Are spinal " presynaptic" inhibitory mechanisms suppressed in spasticity?. J Neurol Sci 1972, 15:321-326.
14. Burne J.A., Carleton V.L., O'Dwyer N.J. The spasticity paradox: movement disorder or disorder of resting limbs?. J Neurol Neurosurg Psychiatry 2005, 76:47-54.
15. Bussel B., Roby-Brami A., Azouvi P., et al. Myoclonus in a patient with spinal cord transection. Possible involvement of the spinal stepping generator. Brain 1988, 111:1235-1245.
16. Carr L.J., Harrison L.M., Evans A.L., et al. Patterns of central motor reorganization in hemiplegic cerebral palsy. Brain 1993, 116:1223-1247.
17. Centonze D., Koch G., Versace V., et al. Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis. Neurology 2007, 68:1045-1050.
18. Christensen L.O., Andersen J.B., Sinkjaer T., et al. Transcranial magnetic stimulation and stretch reflexes in the tibialis anterior muscle during human walking. J Physiol 2001, 531:545-557.
19. Chung S.G., van Rey E., Bai Z., et al. Separate quantification of reflex and nonreflex components of spastic hypertonia in chronic hemiparesis. Arch Phys Med Rehabil 2008, 89:700-710.
20. Coffey J.R., Cahill D., Steers W., et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993, 78:226-232.
21. Condliffe E.G., Clark D.J., Patten C. Reliability of elbow stretch reflex assessment in chronic post-stroke hemiparesis. Clin Neurophysiol 2005, 116:1870-1878.
22. Corry I.S., Cosgrove A.P., Walsh E.G., et al. Botulinum toxin A in the hemiplegic upper limb: a double-blind trial. Dev Med Child Neurol 1997, 39:185-193.
23. Crone C., Nielsen J., Petersen N., et al. Disynaptic reciprocal inhibition of ankle extensors in spastic patients. Brain 1994, 117:1161-1168.
24. Cutter N.C., Scott D.D., Johnson J.C., et al. Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial. Arch Phys Med Rehabil 2000, 81:164-169.
25. Davidoff R.A. Antispasticity drugs: mechanisms of action. Ann Neurol 1985, 17:107-116.
26. Davis D., Jabbari B. Significant improvement of stiff-person syndrome after paraspinal injection of botulinum toxin A. Mov Disord 1993, 8:371-373.
27. Denny-Brown D. Historical aspects of the relation of spasticity to movements. Spasticity: Disordered Motor Control 1980, 1-15. Year Book Medical Publishers, Chicago. R.G. Feldmann, R.R. Young, W.P. Koella (Eds.).
28. Deutsch K.M., Hornby T.G., Schmit B.D. The intralimb coordination of the flexor reflex response is altered in chronic human spinal cord injury. Neurosci Lett 2005, 380:305-310.
29. Dewald J.P., Pope P.S., Given J.D., et al. Abnormal muscle coactivation patterns during isometric torque generation at the elbow and shoulder in hemiparetic subjects. Brain 1995, 118:495-510.
30. Dietrichson P. The fusimotor system in relation to spasticity and parkinsonian rigidity. Scand J Rehabil Med 1973, 5:174-178.
31. Dietz V. Human neuronal control of automatic functional movements: interaction between central programs and afferent input. Physiol Rev 1992, 72:33-69.
32. Dietz V. Neurophysiology of gait disorders: present and future applications. Electroencephalogr Clin Neurophysiol 1997, 103:333-355.
33. Dietz V. Proprioception and locomotor disorders. Nat Rev Neurosci 2002, 3:781-790.
34. Dietz V. Spastic movement disorder: what is the impact of research on clinical practice?. J Neurol Neurosurg Psychiatry 2003, 74:820-821.
35. Dietz V. Spinal cord pattern generators for locomotion. Clin Neurophysiol 2003, 114:1379-1389.
36. Dietz V. Studies on the spastic rat: an adequate model for human spastic movement disorder?. J Neurophysiol 2008, 99:1039-1040. author reply 1041.
37. Dietz V., Berger W. Normal and impaired regulation of muscle stiffness in gait: a new hypothesis about muscle hypertonia. Exp Neurol 1983, 79:680-687.
38. Dietz V., Sinkjaer T. Spastic movement disorder: impaired reflex function and altered muscle mechanics. Lancet Neurol 2007, 6:725-733.
39. Dietz V., Young R. The syndrome of spastic paresis. Neurological Disorders. Course and Treatment 2003, 1247-1257. Academic Press, Amsterdam. T. Brandt, L. Caplan, J. Dichgans (Eds.).
40. Dietz V., Quintern J., Berger W. Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia. Brain 1981, 104:431-449.
41. Dietz V., Ketelsen U.P., Berger W., et al. Motor unit involvement in spastic paresis. Relationship between leg muscle activation and histochemistry. J Neurol Sci 1986, 75:89-103.
42. Dietz V., Trippel M., Berger W. Reflex activity and muscle tone during elbow movements in patients with spastic paresis. Ann Neurol 1991, 30:767-779.
43. Dietz V., Colombo G., Jensen L. Locomotor activity in spinal man. Lancet 1994, 344:1260-1263.
44. Diserens K., Perret N., Chatelain S., et al. The effect of repetitive arm cycling on post stroke spasticity and motor control: repetitive arm cycling and spasticity. J Neurol Sci 2007, 253:18-24.
45. Ditunno J.F., Little J.W., Tessler A., et al. Spinal shock revisited: a four-phase model. Spinal Cord 2004, 42:383-395.
46. Dressnandt J., Conrad B. Lasting reduction of severe spasticity after ending chronic treatment with intrathecal baclofen. J Neurol Neurosurg Psychiatry 1996, 60:168-173.
47. Duncan G.W., Shahani B.T., Young R.R. An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions. A double-blind, cross-over study. Neurology 1976, 26:441-446.
48. Edstrom L. Selective changes in the sizes of red and white muscle fibres in upper motor lesions and Parkinsonism. J Neurol Sci 1970, 11:537-550.
49. Faist M., Mazevet D., Dietz V., et al. A quantitative assessment of presynaptic inhibition of Ia afferents in spastics. Differences in hemiplegics and paraplegics. Brain 1994, 117:1449-1455.
50. Faist M., Dietz V., Pierrot-Deseilligny E. Modulation, probably presynaptic in origin, of monosynaptic Ia excitation during human gait. Exp Brain Res 1996, 109:441-449.
51. Faist M., Ertel M., Berger W., et al. Impaired modulation of quadriceps tendon jerk reflex during spastic gait: differences between spinal and cerebral lesions. Brain 1999, 122:567-579.
52. Foran J.R., Steinman S., Barash I., et al. Structural and mechanical alterations in spastic skeletal muscle. Dev Med Child Neurol 2005, 47:713-717.
53. Fung J., Barbeau H. Effects of conditioning cutaneomuscular stimulation on the soleus H-reflex in normal and spastic paretic subjects during walking and standing. J Neurophysiol 1994, 72:2090-2104.
54. Galiana L., Fung J., Kearney R. Identification of intrinsic and reflex ankle stiffness components in stroke patients. Exp Brain Res 2005, 165:422-434.
55. Giuliani C.A. Dorsal rhizotomy for children with cerebral palsy: support for concepts of motor control. Phys Ther 1991, 71:248-259.
56. Glenn M.B., Whyte J. The Practical Management of Spasticity in Children and Adults 1990, Lea & Febige, Philadelphia.
57. Goldberger M.E., Murray M. Patterns of sprouting and implications for recovery of function. Adv Neurol 1988, 47:361-385.
58. Gorassini M.A., Knash M.E., Harvey P.J., et al. Role of motoneurons in the generation of muscle spasms after spinal cord injury. Brain 2004, 127:2247-2258.
59. Gracies J.M. Pathophysiology of impairment in patients with spasticity and use of stretch as a treatment of spastic hypertonia. Phys Med Rehabil Clin N Am 2001, 12:747-768.
60. Gracies J.M. Pathophysiology of spastic paresis. I. Paresis and soft tissue changes. Muscle Nerve 2005, 31:535-551.
61. Hagbarth K.E., Wallin G., Lofstedt L. Muscle spindle responses to stretch in normal and spastic subjects. Scand J Rehabil Med 1973, 5:156-159.
62. Hattab J.R. Review of European clinical trials with baclofen. Spasticity: Disordered Motor Control 1980, 71-85. Year Book, Chicago. R.G. Feldman, R.R. Young, W.P. Koella (Eds.).
63. Hecht M.J., Stolze H., Auf dem Brinke M., et al. Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia - report of 19 cases. Mov Disord 2008, 23:228-233.
64. Hiersemenzel L.P., Curt A., Dietz V. From spinal shock to spasticity: neuronal adaptations to a spinal cord injury. Neurology 2000, 54:1574-1582.
65. Hoogstraten M.C., van der Ploeg R.J., vd Burg W., et al. Tizanidine versus baclofen in the treatment of spasticity in multiple sclerosis patients. Acta Neurol Scand 1988, 77:224-230.
66. Hornby T.G., Rymer W.Z., Benz E.N., et al. Windup of flexion reflexes in chronic human spinal cord injury: a marker for neuronal plateau potentials?. J Neurophysiol 2003, 89:416-426.
67. Hufschmidt A., Mauritz K.H. Chronic transformation of muscle in spasticity: a peripheral contribution to increased tone. J Neurol Neurosurg Psychiatry 1985, 48:676-685.
68. Ibrahim I.K., Berger W., Trippel M., et al. Stretch-induced electromyographic activity and torque in spastic elbow muscles. Differential modulation of reflex activity in passive and active motor tasks. Brain 1993, 116:971-989.
69. Jones C.A., Yang J.F. Reflex behavior during walking in incomplete spinal-cord-injured subjects. Exp Neurol 1994, 128:239-248.
70. Kamper D.G., Schmit B.D., Rymer W.Z. Effect of muscle biomechanics on the quantification of spasticity. Ann Biomed Eng 2001, 29:1122-1134.
71. Kamper D.G., Harvey R.L., Suresh S., et al. Relative contributions of neural mechanisms versus muscle mechanics in promoting finger extension deficits following stroke. Muscle Nerve 2003, 28:309-318.
72. Kautz S.A., Patten C., Neptune R.R. Does unilateral pedaling activate a rhythmic locomotor pattern in the nonpedaling leg in post-stroke hemiparesis?. J Neurophysiol 2006, 95:3154-3163.
73. Knikou M., Conway B.A. Effects of electrically induced muscle contraction on flexion reflex in human spinal cord injury. Spinal Cord 2005, 43:640-648.
74. Knutsson E., Richards C. Different types of disturbed motor control in gait of hemiparetic patients. Brain 1979, 102:405-430.
75. Knutsson E., Martensson A., Gransberg L. Influences of muscle stretch reflexes on voluntary, velocity-controlled movements in spastic paraparesis. Brain 1997, 120:1621-1633.
76. Kwakkel G., Wagenaar R.C., Twisk J.W., et al. Intensity of leg and arm training after primary middle-cerebral-artery stroke: a randomised trial. Lancet 1999, 354:191-196.
77. Laitinen L.V., Nilsson S., Fugl-Meyer A.R. Selective posterior rhizotomy for treatment of spasticity. J Neurosurg 1983, 58:895-899.
78. Lam T., Wirz M., Lunenburger L., et al. Swing phase resistance enhances flexor muscle activity during treadmill locomotion in incomplete spinal cord injury. Neurorehabil Neural Repair 2008, 22:438-446.
79. Lance J. Symposium synopsis. Spasticity: Disordered Motor Control 1980, 485-495. Year Book Medical Publishers, Chicago. R.G. Feldman, R.R. Young, W.P. Koella (Eds.).
80. Lapierre Y., Bouchard S., Tansey C., et al. Treatment of spasticity with tizanidine in multiple sclerosis. Can J Neurol Sci 1987, 14:513-517.
81. Latash M., Anson J. What are " normal movements" in atypic populations?. Behav Brain Sci 1996, 19:55-106.
82. Latash M.L., Penn R.D. Changes in voluntary motor control induced by intrathecal baclofen in patients with spasticity of different etiology. Physiother Res Int 1996, 1:229-246.
83. Latash M.L., Penn R.D., Corcos D.M., et al. Short-term effects of intrathecal baclofen in spasticity. Exp Neurol 1989, 103:165-172.
84. Levin M.F., Feldman A.G. The role of stretch reflex threshold regulation in normal and impaired motor control. Brain Res 1994, 657:23-30.
85. Levin M.F., Selles R.W., Verheul M.H., et al. Deficits in the coordination of agonist and antagonist muscles in stroke patients: implications for normal motor control. Brain Res 2000, 853:352-369.
86. Liddell E.G.T., Sherrington C. Reflexes in response to stretch (myotatic reflexes). Proc R Soc Lond B Biol Sci 1924, 96:212-242.
87. Lieber R.L., Friden J. Spasticity causes a fundamental rearrangement of muscle-joint interaction. Muscle Nerve 2002, 25:265-270.
88. Lieber R.L., Steinman S., Barash I.A., et al. Structural and functional changes in spastic skeletal muscle. Muscle Nerve 2004, 29:615-627.
89. Little J.W., Ditunno J.F., Stiens S.A., et al. Incomplete spinal cord injury: neuronal mechanisms of motor recovery and hyperreflexia. Arch Phys Med Rehabil 1999, 80:587-599.
90. Lum P.S., Patten C., Kothari D., et al. Effects of velocity on maximal torque production in poststroke hemiparesis. Muscle Nerve 2004, 30:732-742.
91. McLaughlin J.F., Bjornson K.F., Astley S.J., et al. Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial. Dev Med Child Neurol 1998, 40:220-232.
92. Maegele M., Muller S., Wernig A., et al. Recruitment of spinal motor pools during voluntary movements versus stepping after human spinal cord injury. J Neurotrauma 2002, 19:1217-1229.
93. Malouin F., Bonneau C., Pichard L., et al. Non-reflex mediated changes in plantarflexor muscles early after stroke. Scand J Rehabil Med 1997, 29:147-153.
94. Marciniak C., Rader L., Gagnon C. The use of botulinum toxin for spasticity after spinal cord injury. Am J Phys Med Rehabil 2008, 87:312-317. quiz 318-320, 329.
95. Marita H., Shinds M., Momoi H., et al. Lack of modulation of Ib inhibition during antagonist contraction in spasticity. Neurology 2006, 67:52-56.
96. Marque P., Simonetta-Moreau M., Maupas E., et al. Facilitation of transmission in heteronymous group II pathways in spastic hemiplegic patients. J Neurol Neurosurg Psychiatry 2001, 70:36-42.
97. Mazzaro N., Nielsen J.F., Grey M.J., et al. Decreased contribution from afferent feedback to the soleus muscle during walking in patients with spastic stroke. Journal of Stroke and Cerebrovascular Diseases 2007, 16:135-144.
98. Mazzocchio R., Rossi A. Involvement of spinal recurrent inhibition in spasticity. Further insight into the regulation of Renshaw cell activity. Brain 1997, 120:991-1003.
99. Mendell L.M. Modifiability of spinal synapses. Physiol Rev 1984, 64:260-324.
100. Meythaler J.M., Guin-Renfroe S., Hadley M.N. Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report. Am J Phys Med Rehabil 1999, 78:247-254.
101. Mirbagheri M.M., Barbeau H., Ladouceur M., et al. Intrinsic and reflex stiffness in normal and spastic, spinal cord injured subjects. Exp Brain Res 2001, 141:446-459.
102. Miscio G., Del Conte C., Pianca D., et al. Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications. J Neurol 2004, 251:189-196.
103. Muller R., Dietz V. Neuronal function in chronic spinal cord injury: divergence between locomotor and flexion- and H-reflex activity. Clin Neurophysiol 2006, 117:1499-1507.
104. Nacimiento W., Mautes A., Topper R., et al. B-50 (GAP-43) in the spinal cord caudal to hemisection: indication for lack of intraspinal sprouting in dorsal root axons. J Neurosci Res 1993, 35:603-617.
105. Nardone A., Schieppati M. Reflex contribution of spindle group Ia and II afferent input to leg muscle spasticity as revealed by tendon vibration in hemiparesis. Clin Neurophysiol 2005, 116:1370-1381.
106. Nardone A., Galante M., Lucas B., et al. Stance control is not affected by paresis and reflex hyperexcitability: the case of spastic patients. J Neurol Neurosurg Psychiatry 2001, 70:635-643.
107. Nielsen J.F., Sinkjaer T. A comparison of clinical and laboratory measures of spasticity. Mult Scler 1996, 1:296-301.
108. Nielsen J., Petersen N., Crone C. Changes in transmission across synapses of Ia afferents in spastic patients. Brain 1995, 118:995-1004.
109. Nielsen J.B., Petersen N.T., Crone C., et al. Stretch reflex regulation in healthy subjects and patients with spasticity. Neuromodulation: Technology at the Neural Interface 2005, 8:49-57.
110. Nielsen J.B., Crone C., Hultborn H. The spinal pathophysiology of spasticity - from a basic science point of view. Acta Physiol (Oxf) 2007, 189:171-180.
111. Ochs G., Struppler A., Meyerson B.A., et al. Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. J Neurol Neurosurg Psychiatry 1989, 52:933-939.
112. O'Dwyer N.J., Ada L. Reflex hyperexcitability and muscle contracture in relation to spastic hypertonia. Curr Opin Neurol 1996, 9:451-455.
113. O'Dwyer N.J., Ada L., Neilson P.D. Spasticity and muscle contracture following stroke. Brain 1996, 119:1737-1749.
114. Okuma Y., Lee R.G. Reciprocal inhibition in hemiplegia: correlation with clinical features and recovery. Can J Neurol Sci 1996, 23:15-23.
115. Ozcakir S., Sivrioglu K. Botulinum toxin in poststroke spasticity. Clin Med Res 2007, 5:132-138.
116. Peacock W.J., Staudt L.A. Functional outcomes following selective posterior rhizotomy in children with cerebral palsy. J Neurosurg 1991, 74:380-385.
117. Pease W.S. Therapeutic electrical stimulation for spasticity: quantitative gait analysis. Am J Phys Med Rehabil 1998, 77:351-355.
118. Penn R.D., Gottlieb G.L., Agarwal G.C. Cerebellar stimulation in man. Quantitative changes in spasticity. J Neurosurg 1978, 48:779-786.
119. Penn R.D., Savoy S.M., Corcos D., et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989, 320:1517-1521.
120. Pin T., Dyke P., Chan M. The effectiveness of passive stretching in children with cerebral palsy. Dev Med Child Neurol 2006, 48:855-862.
121. Popovic M.R., Keller T., Pappas I.P., et al. Surface-stimulation technology for grasping and walking neuroprosthesis. IEEE Eng Med Biol Mag 2001, 20:82-93.
122. Powers R.K., Marder-Meyer J., Rymer W.Z. Quantitative relations between hypertonia and stretch reflex threshold in spastic hemiparesis. Ann Neurol 1988, 23:115-124.
123. Putty T.K., Shapiro S.A. Efficacy of dorsal longitudinal myelotomy in treating spinal spasticity: a review of 20 cases. J Neurosurg 1991, 75:397-401.
124. Remy-Neris O., Denys P., Daniel O., et al. Effect of intrathecal clonidine on group I and group II oligosynaptic excitation in paraplegics. Exp Brain Res 2003, 148:509-514.
125. Rosenfalck A., Andreassen S. Impaired regulation of force and firing pattern of single motor units in patients with spasticity. J Neurol Neurosurg Psychiatry 1980, 43:907-916.
126. Rushworth G. Spasticity and rigidity: an experimental study and review. J Neurol Neurosurg Psychiatry 1960, 23:99-118.
127. Sadiq S.A., Wang G.C. Long-term intrathecal baclofen therapy in ambulatory patients with spasticity. J Neurol 2006, 253:563-569.
128. Sakamato T., Porte L.L., Asanuma H. Functional rote of the sensory cortex in learning motor skills in cats. Brain Res 1989, 503:258-264.
129. Schmit B.D., McKenna-Cole A., Rymer W.Z. Flexor reflexes in chronic spinal cord injury triggered by imposed ankle rotation. Muscle Nerve 2000, 23:793-803.
130. Schmit B.D., Benz E.N., Rymer W.Z. Afferent mechanisms for the reflex response to imposed ankle movement in chronic spinal cord injury. Exp Brain Res 2002, 145:40-49.
131. Schomburg E.D., Steffens H. The effect of DOPA and clonidine on reflex pathways from group II muscle afferents to alpha-motoneurones in the cat. Exp Brain Res 1988, 71:442-446.
132. Schurch B. Errors and limitations of the multimodality checking methods of defective spinal intrathecal pump systems. Case report. Paraplegia 1993, 31:611-615.
133. Schurch B., Hauri D., Rodic B., et al. Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 1996, 155:1023-1029.
134. Scott B.A., Weinstein Z., Chiteman R., et al. Intrathecal phenol and glycerin in metrizamide for treatment of intractable spasms in paraplegia. Case report. J Neurosurg 1985, 63:125-127.
135. Seib T.P., Price R., Reyes M.R., et al. The quantitative measurement of spasticity: effect of cutaneous electrical stimulation. Arch Phys Med Rehabil 1994, 75:746-750.
136. Sheean G. The pathophysiology of spasticity. Eur J Neurol 2002, 9:3-9. discussion 53-61.
137. Shefner J.M., Berman S.A., Sarkarati M., et al. Recurrent inhibition is increased in patients with spinal cord injury. Neurology 1992, 42:2162-2168.
138. Simpson D.M., Gracies J.M., Graham H.K., et al. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008, 70:1691-1698.
139. Sinkjaer T., Magnussen I. Passive, intrinsic and reflex-mediated stiffness in the ankle extensors of hemiparetic patients. Brain 1994, 117:355-363.
140. Sinkjaer T., Toft E., Andreassen S., et al. Muscle stiffness in human ankle dorsiflexors: intrinsic and reflex components. J Neurophysiol 1988, 60:1110-1121.
141. Sinkjaer T., Toft E., Larsen K., et al. Non-reflex and reflex mediated ankle joint stiffness in multiple sclerosis patients with spasticity. Muscle Nerve 1993, 16:69-76.
142. Sinkjaer T., Toft E., Hansen H.J. H-reflex modulation during gait in multiple sclerosis patients with spasticity. Acta Neurol Scand 1995, 91:239-246.
143. Sinkjaer T., Andersen J.B., Nielsen J.F. Impaired stretch reflex and joint torque modulation during spastic gait in multiple sclerosis patients. J Neurol 1996, 243:566-574.
144. Sinkjaer T., Andersen J.B., Nielsen J.F., et al. Soleus long-latency stretch reflexes during walking in healthy and spastic humans. Clin Neurophysiol 1999, 110:951-959.
145. Sonde L., Kalimo H., Fernaeus S.E., et al. Low TENS treatment on post-stroke paretic arm: a three-year follow-up. Clin Rehabil 2000, 14:14-19.
146. Stewart-Wynne E.G., Silbert P.L., Buffery S., et al. Intrathecal baclofen for severe spasticity: five years experience. Clin Exp Neurol 1991, 28:244-255.
147. Stien R., Nordal H.J., Oftedal S.I., et al. The treatment of spasticity in multiple sclerosis: a double-blind clinical trial of a new anti-spastic drug tizanidine compared with baclofen. Acta Neurol Scand 1987, 75:190-194.
148. Thach W., Montgomery E. Motor systems. Neurobiology Disease 1990, 168-196. Oxford University Press, Oxford. A. Pearlman, R. Collins (Eds.).
149. Thilmann A.F., Fellows S.J., Ross H.F. Biomechanical changes at the ankle joint after stroke. J Neurol Neurosurg Psychiatry 1991, 54:134-139.
150. Toft E., Sinkjaer T., Andreassen S., et al. Mechanical and electromyographic responses to stretch of the human ankle extensors. J Neurophysiol 1991, 65:1402-1410.
151. Toft E., Sinkjaer T., Andreassen S., et al. Stretch responses to ankle rotation in multiple sclerosis patients with spasticity. Electroencephalogr Clin Neurophysiol 1993, 89:311-318.
152. Trompetto C., Curra A., Buccolieri A., et al. Botulinum toxin changes intrafusal feedback in dystonia: a study with the tonic vibration reflex. Mov Disord 2006, 21:777-782.
153. Vallbo A.B., Hagbarth K.E., Torebjork H.E., et al. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 1979, 59:919-957.
154. Vattanasilp W., Ada L., Crosbie J. Contribution of thixotropy, spasticity, and contracture to ankle stiffness after stroke. J Neurol Neurosurg Psychiatry 2000, 69:34-39.
155. Visintin M., Barbeau H. The effects of body weight support on the locomotor pattern of spastic paretic patients. Can J Neurol Sci 1989, 16:315-325.
156. Weingarden H.P., Zeilig G., Heruti R., et al. Hybrid functional electrical stimulation orthosis system for the upper limb: effects on spasticity in chronic stable hemiplegia. Am J Phys Med Rehabil 1998, 77:276-281.
157. Wernig A., Muller S., Nanassy A., et al. Laufband therapy based on " rules of spinal locomotion" is effective in spinal cord injured persons. Eur J Neurosci 1995, 7:823-829.
158. Wiesendanger M. Neurobiology of spasticity. Spasticity 1989, 45-61. The Current Status of Research and Treatment. New Trends in Clinical Neurology, Parthenon, Carnforth. M. Emre, R. Benecke (Eds.).
159. Wiesendanger M., Chapman C.E., Marini G., et al. Experimental studies of dorsal cord stimulation in animal model of spasticity. Clinical Neurophysiology in Spasticity 1985, 205-219. Elsevier, Amsterdam. P.J. Delwaide, R.R. Young (Eds.).
160. Wilson L.R., Gandevia S.C., Inglis J.T., et al. Muscle spindle activity in the affected upper limb after a unilateral stroke. Brain 1999, 122:2079-2088.
161. Wirz M., van Hedel H.J., Rupp R., et al. Muscle force and gait performance: relationships after spinal cord injury. Arch Phys Med Rehabil 2006, 87:1218-1222.
162. Wright F.V., Sheil E.M., Drake J.M., et al. Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: a randomized controlled trial. Dev Med Child Neurol 1998, 40:239-247.